Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220883907> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4220883907 endingPage "646" @default.
- W4220883907 startingPage "646" @default.
- W4220883907 abstract "Schizophrenia (SCZ) is associated with aberrant redox regulation in the early stages of brain development. There is growing evidence that the antioxidant defense system is closely associated with the therapeutic response to antipsychotics in SCZ patients. The aim of this study was to examine the effect of risperidone monotherapy on total antioxidant status (TAS) and the relationship between symptom improvement and changes in TAS in patients with antipsychotic-naïve first-episode (ANFE) SCZ. Clinical symptoms were evaluated using the Positive and Negative Syndrome Scale (PANSS). Two hundred and forty-six ANFE patients were treated with risperidone for 3 months. PANSS and TAS levels were assessed at baseline and at a 3-month follow-up. Relative to healthy controls, ANFE patients had higher TAS levels, which increased even further during the treatment. Moreover, baseline TAS levels were a predictor of symptom reduction after risperidone treatment. In addition, there was a significant association between increased TAS levels and the decreased cognitive factor. Our findings suggest that antioxidant protection is possibly associated with clinical improvement in ANFE patients after risperidone treatment." @default.
- W4220883907 created "2022-04-03" @default.
- W4220883907 creator A5017773158 @default.
- W4220883907 creator A5022946499 @default.
- W4220883907 creator A5043336955 @default.
- W4220883907 creator A5052131001 @default.
- W4220883907 creator A5057991956 @default.
- W4220883907 date "2022-03-28" @default.
- W4220883907 modified "2023-09-30" @default.
- W4220883907 title "Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy" @default.
- W4220883907 cites W1965035280 @default.
- W4220883907 cites W1988775970 @default.
- W4220883907 cites W2000680339 @default.
- W4220883907 cites W2035662662 @default.
- W4220883907 cites W2054998761 @default.
- W4220883907 cites W2061033969 @default.
- W4220883907 cites W2080735674 @default.
- W4220883907 cites W2087747881 @default.
- W4220883907 cites W2094905804 @default.
- W4220883907 cites W2123751589 @default.
- W4220883907 cites W2126925382 @default.
- W4220883907 cites W2217230681 @default.
- W4220883907 cites W2323822074 @default.
- W4220883907 cites W2327629365 @default.
- W4220883907 cites W2581939705 @default.
- W4220883907 cites W2788048790 @default.
- W4220883907 cites W2809761645 @default.
- W4220883907 cites W2885929360 @default.
- W4220883907 cites W2939777586 @default.
- W4220883907 cites W3140915471 @default.
- W4220883907 cites W4230482815 @default.
- W4220883907 doi "https://doi.org/10.3390/antiox11040646" @default.
- W4220883907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35453331" @default.
- W4220883907 hasPublicationYear "2022" @default.
- W4220883907 type Work @default.
- W4220883907 citedByCount "1" @default.
- W4220883907 countsByYear W42208839072023 @default.
- W4220883907 crossrefType "journal-article" @default.
- W4220883907 hasAuthorship W4220883907A5017773158 @default.
- W4220883907 hasAuthorship W4220883907A5022946499 @default.
- W4220883907 hasAuthorship W4220883907A5043336955 @default.
- W4220883907 hasAuthorship W4220883907A5052131001 @default.
- W4220883907 hasAuthorship W4220883907A5057991956 @default.
- W4220883907 hasBestOaLocation W42208839071 @default.
- W4220883907 hasConcept C118552586 @default.
- W4220883907 hasConcept C126322002 @default.
- W4220883907 hasConcept C15744967 @default.
- W4220883907 hasConcept C2776412080 @default.
- W4220883907 hasConcept C2779727114 @default.
- W4220883907 hasConcept C2780057945 @default.
- W4220883907 hasConcept C2780135775 @default.
- W4220883907 hasConcept C2780494398 @default.
- W4220883907 hasConcept C71924100 @default.
- W4220883907 hasConceptScore W4220883907C118552586 @default.
- W4220883907 hasConceptScore W4220883907C126322002 @default.
- W4220883907 hasConceptScore W4220883907C15744967 @default.
- W4220883907 hasConceptScore W4220883907C2776412080 @default.
- W4220883907 hasConceptScore W4220883907C2779727114 @default.
- W4220883907 hasConceptScore W4220883907C2780057945 @default.
- W4220883907 hasConceptScore W4220883907C2780135775 @default.
- W4220883907 hasConceptScore W4220883907C2780494398 @default.
- W4220883907 hasConceptScore W4220883907C71924100 @default.
- W4220883907 hasIssue "4" @default.
- W4220883907 hasLocation W42208839071 @default.
- W4220883907 hasLocation W42208839072 @default.
- W4220883907 hasLocation W42208839073 @default.
- W4220883907 hasOpenAccess W4220883907 @default.
- W4220883907 hasPrimaryLocation W42208839071 @default.
- W4220883907 hasRelatedWork W1975413208 @default.
- W4220883907 hasRelatedWork W1983945019 @default.
- W4220883907 hasRelatedWork W2054265020 @default.
- W4220883907 hasRelatedWork W2089873036 @default.
- W4220883907 hasRelatedWork W2091458407 @default.
- W4220883907 hasRelatedWork W2097768453 @default.
- W4220883907 hasRelatedWork W2291501000 @default.
- W4220883907 hasRelatedWork W2373455425 @default.
- W4220883907 hasRelatedWork W2387957321 @default.
- W4220883907 hasRelatedWork W2972661286 @default.
- W4220883907 hasVolume "11" @default.
- W4220883907 isParatext "false" @default.
- W4220883907 isRetracted "false" @default.
- W4220883907 workType "article" @default.